Screener
Arbutus Biopharma Corporation ABUS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The source filing: Arbutus Biopharma Corporation’s 10-K, filed March 23, 2026. Open the filing →
- Filed
- Mar 23, 2026, 7:30 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001447028-26-000017
FAQ
- What is Arbutus Biopharma Corporation's free cash flow?
- Arbutus Biopharma Corporation (ABUS) reported free cash flow of -$4.68M in Q4 2025.
- How has Arbutus Biopharma Corporation's free cash flow changed year-over-year?
- Arbutus Biopharma Corporation's free cash flow increased by 55.0% year-over-year, from -$10.4M to -$4.68M.
- What is the long-term trend for Arbutus Biopharma Corporation's free cash flow?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's free cash flow has grown at a -12.7% compound annual growth rate (CAGR), from -$68.34M to -$39.64M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Arbutus Biopharma Corporation's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude